PharmaKinetics Laboratories Inc. Report issue

For profit Phase 1
Founded: Baltimore MD United States (1976)
Status: Acquired by Bioanalytical Systems, Inc. (2003)

Organization Overview

First Clinical Trial
1988
NCT00913419
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

PharmaKinetic Ltd | PharmaKineticsLaboratories, Inc

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 1)

Hypertension (Phase 1)

Malnutrition (Phase 1)

Osteoarthritis (Phase 1)

Rheumatic Diseases (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 12
  • # of Trial APIs: 10